Cancer incidence before and after kidney transplantation

被引:861
作者
Vajdic, Claire M.
McDonald, Stephen P.
McCredie, Margaret R. E.
van Leeuwen, Marina T.
Stewart, John H.
Law, Matthew
Chapman, Jeremy R.
Webster, Angela C.
Kaldor, John M.
Grulich, Andrew E.
机构
[1] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
[2] Queen Elizabeth Hosp, Australia & New Zealand Dialysis & Transplant Reg, Adelaide, SA, Australia
[3] Univ Adelaide, Discipline Med, Adelaide, SA, Australia
[4] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia
[5] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand
[6] Univ Sydney, Westmead Hosp, Millennium Inst, Ctr Transplant & Renal Res, Sydney, NSW 2006, Australia
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 296卷 / 23期
关键词
D O I
10.1001/jama.296.23.2823
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Immune suppression after organ transplantation is associated with a markedly increased risk of nonmelanoma skin cancer and a few virus-associated cancers. Although it is generally accepted that other cancers do not occur at increased rates, there have been few long-term population-based cohort studies performed. Objective To compare the incidence of cancer in patients receiving immune suppression after kidney transplantation with incidence in the same population in 2 periods before receipt of immune suppression: during dialysis and during end-stage kidney disease before renal replacement therapy (RRT). Design, Setting, and Participants A population-based cohort study of 28 855 patients with end-stage kidney disease who received RRT, with 273 407 person-years of follow-up. Incident cancers (1982-2003) were ascertained by record linkage between the Australia and New Zealand Dialysis and Transplant Registry and the Australian National Cancer Statistics Clearing House. Main Outcome Measure Standardized incidence ratios (SIRs) of cancer, using age-specific, sex-specific, calendar year - specific, and state/territory-specific population cancer incidence rates. Results The overall incidence of cancer, excluding nonmelanoma skin cancer and those cancers known to frequently cause end-stage kidney disease, was markedly increased after transplantation (n= 1236; SIR, 3.27; 95% confidence interval [CI], 3.09-3.46). In contrast, cancer incidence was only slightly increased during dialysis ( n= 870; SIR, 1.35; 95% CI, 1.27-1.45) and before RRT ( n= 689; SIR, 1.16; 95% CI, 1.08-1.25). After transplantation, cancer occurred at significantly increased incidence at 25 sites, and risk exceeded 3-fold at 18 of these sites. Most of these cancers were of known or suspected viral etiology. Conclusions Kidney transplantation is associated with a marked increase in cancer risk at a wide variety of sites. Because SIRs for most types of cancer were not increased before transplantation, immune suppression may be responsible for the increased risk. These data suggest a broader than previously appreciated role of the interaction between the immune system and common viral infections in the etiology of cancer.
引用
收藏
页码:2823 / 2831
页数:9
相关论文
共 31 条
  • [1] *AIHW, 2005, 57 AIHW PHE
  • [2] *AIHW AACR, 2001, CANC SER, V19
  • [3] *AIHW AACR, 2004, CANC SER, V28
  • [4] [Anonymous], IARC MON EV CARC RIS
  • [5] [Anonymous], IARC MON EV CARC RIS
  • [6] [Anonymous], IARC MON EV CARC RIS
  • [7] Cancer risk in patients on dialysis and after renal transplantation
    Birkeland, SA
    Lokkegaard, H
    Storm, HH
    [J]. LANCET, 2000, 355 (9218) : 1886 - 1887
  • [8] CANCER RISK AFTER RENAL-TRANSPLANTATION IN THE NORDIC COUNTRIES, 1964-1986
    BIRKELAND, SA
    STORM, HH
    LAMM, LU
    BARLOW, L
    BLOHME, I
    FORSBERG, B
    EKLUND, B
    FJELDBORG, O
    FRIEDBERG, M
    FRODIN, L
    GLATTRE, E
    HALVORSEN, S
    HOLM, NV
    JAKOBSEN, A
    JORGENSEN, HE
    LADEFOGED, J
    LINDHOLM, T
    LUNDGREN, G
    PUKKALA, E
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (02) : 183 - 189
  • [9] Carcinogenicity of human papillomaviruses
    Cogliano, V
    Baan, R
    Straif, K
    Grosse, Y
    Secretan, B
    El Ghissassi, F
    [J]. LANCET ONCOLOGY, 2005, 6 (04) : 204 - 204
  • [10] Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome
    Frisch, M
    Biggar, IJ
    Goedert, JJ
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18): : 1500 - 1510